Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Morra

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of Experimental & Clinical Cancer Research : CR|August 13, 2022
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinomaFrancesco Morra, Francesco Merolla, Giovanna Damia, et al.
AJNR. American Journal of Neuroradiology|March 26, 2026
Smokers with Large Vessel Occlusion Stroke Show Poor Leptomeningeal CollateralsHakim Baazaoui, Francesco Morra, Lukas Bastian Otto, et al.
Cancer Letters|February 8, 2022
Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancerCaterina Miro, Angelo Di Giovanni, Melania Murolo, et al.
Journal of Affective Disorders|June 28, 2022
Altered brain regional homogeneity is associated with depressive symptoms in COVID-19Giulia Cattarinussi, Alessandro Miola, Nicolò Trevisan, et al.
Apoptosis : an International Journal on Programmed Cell Death|July 14, 2026
KRAS-mediated CCDC6 degradation drives xCT upregulation and ferroptosis evasionDaniela Criscuolo, Rosaria Catalano, Carmela Baviello, et al.
Chemical Senses|November 7, 2024
Late olfactory bulb involvement in COVID-19Francesco Morra, Matteo Minerva, Silvia Valeggia, et al.
Oncotarget|April 18, 2015
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLCFrancesco Morra, Chiara Luise, Francesco Merolla, et al.
International Journal of Cancer|October 11, 2014
New therapeutic perspectives in CCDC6 deficient lung cancer cellsFrancesco Morra, Chiara Luise, Roberta Visconti, et al.
Cancer Research Communications|December 19, 2025
CCDC6 immunostaining in conjunction with the Rad51 HRD assay may expand PARPi treatment eligibility in HGSOC patientsDaniela Criscuolo, Francesco Merolla, Benedetta Pellegrino, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of Experimental & Clinical Cancer Research : CR|August 13, 2022
The disruption of the CCDC6 - PP4 axis induces a BRCAness like phenotype and sensitivity to PARP inhibitors in high-grade serous ovarian carcinomaFrancesco Morra, Francesco Merolla, Giovanna Damia, et al.
AJNR. American Journal of Neuroradiology|March 26, 2026
Smokers with Large Vessel Occlusion Stroke Show Poor Leptomeningeal CollateralsHakim Baazaoui, Francesco Morra, Lukas Bastian Otto, et al.
Cancer Letters|February 8, 2022
Thyroid hormone and androgen signals mutually interplay and enhance inflammation and tumorigenic activation of tumor microenvironment in prostate cancerCaterina Miro, Angelo Di Giovanni, Melania Murolo, et al.
Journal of Affective Disorders|June 28, 2022
Altered brain regional homogeneity is associated with depressive symptoms in COVID-19Giulia Cattarinussi, Alessandro Miola, Nicolò Trevisan, et al.
Apoptosis : an International Journal on Programmed Cell Death|July 14, 2026
KRAS-mediated CCDC6 degradation drives xCT upregulation and ferroptosis evasionDaniela Criscuolo, Rosaria Catalano, Carmela Baviello, et al.
Chemical Senses|November 7, 2024
Late olfactory bulb involvement in COVID-19Francesco Morra, Matteo Minerva, Silvia Valeggia, et al.
Oncotarget|April 18, 2015
FBXW7 and USP7 regulate CCDC6 turnover during the cell cycle and affect cancer drugs susceptibility in NSCLCFrancesco Morra, Chiara Luise, Francesco Merolla, et al.
International Journal of Cancer|October 11, 2014
New therapeutic perspectives in CCDC6 deficient lung cancer cellsFrancesco Morra, Chiara Luise, Roberta Visconti, et al.
Cancer Research Communications|December 19, 2025
CCDC6 immunostaining in conjunction with the Rad51 HRD assay may expand PARPi treatment eligibility in HGSOC patientsDaniela Criscuolo, Francesco Merolla, Benedetta Pellegrino, et al.
Pageof 3